Judit Megyesi

4.9k total citations
69 papers, 4.1k citations indexed

About

Judit Megyesi is a scholar working on Molecular Biology, Pathology and Forensic Medicine and Nephrology. According to data from OpenAlex, Judit Megyesi has authored 69 papers receiving a total of 4.1k indexed citations (citations by other indexed papers that have themselves been cited), including 37 papers in Molecular Biology, 24 papers in Pathology and Forensic Medicine and 22 papers in Nephrology. Recurrent topics in Judit Megyesi's work include Chemotherapy-induced organ toxicity mitigation (18 papers), Acute Kidney Injury Research (15 papers) and Cancer-related Molecular Pathways (11 papers). Judit Megyesi is often cited by papers focused on Chemotherapy-induced organ toxicity mitigation (18 papers), Acute Kidney Injury Research (15 papers) and Cancer-related Molecular Pathways (11 papers). Judit Megyesi collaborates with scholars based in United States, Hungary and United Kingdom. Judit Megyesi's co-authors include Robert Safirstein, Peter M. Price, Didier Portilla, István Arany, Nóra Udvarhelyi, Shenyang Li, Hideaki Kaneto, Kiran K. Nagothu, John F. Dimari and Adel Tarcsafalvi and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Investigation and PLoS ONE.

In The Last Decade

Judit Megyesi

68 papers receiving 4.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Judit Megyesi United States 36 1.8k 1.3k 1.2k 609 377 69 4.1k
Robert Safirstein United States 42 2.5k 1.4× 1.5k 1.2× 2.2k 1.8× 986 1.6× 551 1.5× 89 5.9k
Ganesan Ramesh United States 37 2.1k 1.1× 1.4k 1.1× 2.8k 2.3× 693 1.1× 502 1.3× 66 6.4k
Gur P. Kaushal United States 36 1.6k 0.9× 799 0.6× 790 0.7× 425 0.7× 259 0.7× 56 3.6k
Didier Portilla United States 34 1.7k 1.0× 1.6k 1.2× 577 0.5× 257 0.4× 489 1.3× 68 4.0k
Guie Dong United States 23 1.5k 0.9× 1.0k 0.8× 874 0.7× 181 0.3× 277 0.7× 28 3.1k
Wilfred Lieberthal United States 41 2.4k 1.3× 1.7k 1.3× 871 0.7× 318 0.5× 909 2.4× 79 5.9k
Kwon Moo Park South Korea 33 1.9k 1.0× 1.1k 0.9× 683 0.6× 147 0.2× 726 1.9× 98 4.1k
Navjotsingh Pabla United States 24 1.5k 0.8× 567 0.5× 1.8k 1.5× 871 1.4× 179 0.5× 48 3.8k
Promsuk Jutabha Japan 25 1.4k 0.7× 1.7k 1.3× 730 0.6× 778 1.3× 571 1.5× 66 3.6k
Prabal K. Chatterjee United Kingdom 35 1.4k 0.8× 890 0.7× 684 0.6× 257 0.4× 575 1.5× 67 3.8k

Countries citing papers authored by Judit Megyesi

Since Specialization
Citations

This map shows the geographic impact of Judit Megyesi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Judit Megyesi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Judit Megyesi more than expected).

Fields of papers citing papers by Judit Megyesi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Judit Megyesi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Judit Megyesi. The network helps show where Judit Megyesi may publish in the future.

Co-authorship network of co-authors of Judit Megyesi

This figure shows the co-authorship network connecting the top 25 collaborators of Judit Megyesi. A scholar is included among the top collaborators of Judit Megyesi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Judit Megyesi. Judit Megyesi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Bose, Chhanda, Judit Megyesi, Oleg Karaduta, et al.. (2025). Iron Chelation Prevents Age‐Related Skeletal Muscle Sarcopenia in Klotho Gene Mutant Mice, a Genetic Model of Aging. Journal of Cachexia Sarcopenia and Muscle. 16(1). e13678–e13678. 3 indexed citations
2.
Nowak, Grażyna, Judit Megyesi, & William J. Craigen. (2020). Deletion of VDAC1 Hinders Recovery of Mitochondrial and Renal Functions After Acute Kidney Injury. Biomolecules. 10(4). 585–585. 17 indexed citations
3.
Cameron, Robert B., Whitney S. Gibbs, Tess V. Dupre, et al.. (2019). Proximal Tubule β2-Adrenergic Receptor Mediates Formoterol-Induced Recovery of Mitochondrial and Renal Function after Ischemia-Reperfusion Injury. Journal of Pharmacology and Experimental Therapeutics. 369(1). 173–180. 29 indexed citations
4.
Dupre, Tess V., Mark A. Doll, Parag P. Shah, et al.. (2017). Inhibiting glucosylceramide synthase exacerbates cisplatin-induced acute kidney injury. Journal of Lipid Research. 58(7). 1439–1452. 41 indexed citations
5.
Korrapati, Midhun C., et al.. (2013). Suramin: A Potential Therapy for Diabetic Nephropathy. PLoS ONE. 8(9). e73655–e73655. 17 indexed citations
6.
Hu, Chang-Ping, Bum‐Yong Kang, Judit Megyesi, et al.. (2009). Deletion of LOX-1 attenuates renal injury following angiotensin II infusion. Kidney International. 76(5). 521–527. 31 indexed citations
7.
Munusamy, Shankar, Hamida Saba, Tanecia Mitchell, et al.. (2009). Alteration of renal respiratory Complex-III during experimental type-1 diabetes. BMC Endocrine Disorders. 9(1). 2–2. 37 indexed citations
8.
Megyesi, Judit, Dezső Kelemen, Marcella Mottolese, et al.. (2007). Prognostic factors in Hungarian breast cancer patients.. PubMed. 27(1A). 279–82. 4 indexed citations
9.
Negishi, Kousuke, Eisei Noiri, Takeshi Sugaya, et al.. (2007). A role of liver fatty acid-binding protein in cisplatin-induced acute renal failure. Kidney International. 72(3). 348–358. 61 indexed citations
10.
Portilla, Didier, Kiran K. Nagothu, Judit Megyesi, et al.. (2006). Metabolomic study of cisplatin-induced nephrotoxicity. Kidney International. 69(12). 2194–2204. 142 indexed citations
11.
Arany, István, Judit Megyesi, Barry D. Nelkin, & Robert Safirstein. (2006). STAT3 attenuates EGFR-mediated ERK activation and cell survival during oxidant stress in mouse proximal tubular cells. Kidney International. 70(4). 669–674. 54 indexed citations
12.
Tiwari, Manish, Robert W. Brock, Judit Megyesi, Gur P. Kaushal, & Philip R. Mayeux. (2005). Disruption of renal peritubular blood flow in lipopolysaccharide-induced renal failure: role of nitric oxide and caspases. American Journal of Physiology-Renal Physiology. 289(6). F1324–F1332. 88 indexed citations
13.
Yu, Fang, Judit Megyesi, Robert Safirstein, & Peter M. Price. (2005). Identification of the functional domain of p21WAF1/CIP1that protects cells from cisplatin cytotoxicity. American Journal of Physiology-Renal Physiology. 289(3). F514–F520. 60 indexed citations
14.
Price, Peter M., Judit Megyesi, & Robert Safirstein. (2004). Cell cycle regulation: Repair and regeneration in acute renal failure. Kidney International. 66(2). 509–514. 35 indexed citations
15.
Arany, István, Judit Megyesi, Hideaki Kaneto, Peter M. Price, & Robert Safirstein. (2004). Cisplatin-induced cell death is EGFR/src/ERK signaling dependent in mouse proximal tubule cells. American Journal of Physiology-Renal Physiology. 287(3). F543–F549. 193 indexed citations
16.
Arany, István, Judit Megyesi, Karen Adler‐Storthz, et al.. (2003). Differentiation-dependent expression of signal transducers and activators of transcription (STATs) might modify responses to growth factors in the cancers of the head and neck. Cancer Letters. 199(1). 83–89. 31 indexed citations
17.
Portilla, Didier, Timothy McClure, Richard C. Kurten, et al.. (2002). Alterations of PPARα and its coactivator PGC-1 in cisplatin-induced acute renal failure. Kidney International. 62(4). 1208–1218. 124 indexed citations
18.
Boros, Péter, Adel Tarcsafalvi, Liqing Wang, et al.. (2001). INTRAHEPATIC EXPRESSION AND RELEASE OF VASCULAR ENDOTHELIAL GROWTH FACTOR FOLLOWING ORTHOTOPIC LIVER TRANSPLANTATION IN THE RAT. Transplantation. 72(5). 805–811. 28 indexed citations
19.
Megyesi, Judit, et al.. (2001). Positive effect of the induction of p21WAF1/CIP1 on the course of ischemic acute renal failure. Kidney International. 60(6). 2164–2172. 113 indexed citations
20.
Megyesi, Judit, Robert Safirstein, & Peter M. Price. (1998). Induction of p21WAF1/CIP1/SDI1 in kidney tubule cells affects the course of cisplatin-induced acute renal failure.. Journal of Clinical Investigation. 101(4). 777–782. 238 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Robert Safirstein Breakdown of academic impact, for papers by Ganesan Ramesh Breakdown of academic impact, for papers by Gur P. Kaushal Breakdown of academic impact, for papers by Didier Portilla Breakdown of academic impact, for papers by Guie Dong Breakdown of academic impact, for papers by Wilfred Lieberthal Breakdown of academic impact, for papers by Kwon Moo Park Breakdown of academic impact, for papers by Navjotsingh Pabla Breakdown of academic impact, for papers by Promsuk Jutabha Breakdown of academic impact, for papers by Prabal K. Chatterjee
Rankless by CCL
2026